Intra-Cellular Therapies Inc (MEX:ITCI)
MXN 1529.77 0 (0%) Market Cap: 191.75 Bil Enterprise Value: 172.16 Bil PE Ratio: 0 PB Ratio: 8.38 GF Score: 38/100

Intra-Cellular Therapies, Inc. - Special Call Transcript

Aug 05, 2019 / 12:30PM GMT
Operator

Good morning, ladies and gentlemen, and welcome to the corporate update conference call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Dr. Juan Sanchez, Vice President of Corporate Communications and Investor Relations.

Juan Fernando Sanchez
Intra-Cellular Therapies, Inc. - VP of Corporate Communications & IR

Thank you, operator. Good morning and thank you all for joining us for today's conference call. Our press release providing our corporate update crossed the wire a short time ago and is available on our website at intracellulartherapies.com.

Joining me on the call today are Dr. Sharon Mates, Chairman and Chief Executive Officer; Dr. Andrew Satlin, Executive Vice President and Chief Medical Officer; Dr. Kimberly Vanover, Senior Vice President of Early-Stage Clinical Development and Translational Medicine; and Michael Halstead, Executive Vice President and General Counsel.

As a reminder, during today's call, we will make certain forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot